baber/WOPTO huggingface dataset:
Patent SI-1686880-T1 (SI)
Title: Device for heating foodstuff with hot air
Inventor: BOESCH PATRICK
IPC: A47J39/00
Filed: 2003-11-21
Abstract: The present invention relates to an oven ( 1 ) for heating foodstuff ( 28 ), in particular french fries ( 28 ), by means of hot air ( 22, 23 ) circulating in a substantially closed circle, wherein circulation of the air ( 22, 23 ) is forced, preferably by a fan ( 20 ) or blower. A particularly efficient and fast way of heating can be achieved while at the same time providing ideal crispiness of the foodstuff is made possible in that the foodstuff ( 28 ) is contained in at least one receptacle ( 2 ) at least two of the walls ( 2 a- 2 d) of which are penetrable to the circulating hot air ( 22, 23 ), that the receptacle ( 2 ) is at least partially enclosed towards its penetrable walls ( 2 a- 2 d) by walls ( 4 a- 4 d) of a container ( 4 ), wherein there is a spacing between the respective walls ( 2 a- 2 d) of the receptacle and the walls ( 4 a- 4 d) of the container ( 4 ), that hot air ( 22 ) is entering the receptacle ( 2 ) and/or the container ( 4 ) substantially from an upper side, and that in the region ( 12 ) into which the hot air ( 22 ) is entering the receptacle ( 2 ) and/or the container ( 4 ), the side wall ( 4 a) of the container ( 4 ) is inclined with respect to a horizontal plane by a first angle (alpha) and a corresponding penetrable side wall ( 2 a) of the receptacle ( 2 ) is inclined with respect to said horizontal plane by a second angle ((beta), wherein the first angle (alpha) is larger than the second angle ((beta).
Patent SI-1731605-T1 (SI)
Title: Cancer antigen peptides derived from wt1
Inventor: SUGIYAMA HARUO
IPC: C12P21/02
Filed: 2005-03-30
Abstract: The present invention relates to HLA-A26-binding cancer antigen peptides derived from WT1, polynucleotides encoding said peptide, CTL-inducers, and cancer vaccine comprising said peptide or polynucleotide.
Patent SI-2156932-T1 (SI)
Title: Concrete separator
Inventor: DROLL KLAUS
IPC: B28B7/38
Filed: 2009-05-26
Abstract: A concrete release agent comprises a release agent composition containing organic components selected from a group consisting of mineral oil without solvent, mineral oil with solvent, an emulsion, and ester oil. Nanoparticles are also included in the release agent composition, where the nanoparticles have a photocatalytic effect on the organic components of the release agent composition. The nanoparticles also have absorption spectra, which act in visible light. The concrete release agent comprises a release agent composition containing organic components selected from a group consisting of mineral oil without solvent, mineral oil with solvent, an emulsion, and ester oil. Nanoparticles are also included in the release agent composition, where the nanoparticles have a photocatalytic effect on the organic components of the release agent composition. The nanoparticles also have absorption spectra, which act in visible light. The organic components of the release agent composition are decomposed photocatalytically under daylight to form removable volatile reaction substances.
Patent DE-3486293-T2 (DE)
Inventor: ACREE WILLIAM MARSHALL
IPC: A61K39/39
Filed: 1984-06-14
Granted: 1994-06-30
Abstract: Attenuated live canine coronavirus may be administered to dogs to produce localised immunity to canine coronavirus in the intestines. The attenuated virus may be prepared by passing virulent canine coronavirus in feline cells.
Patent DE-3789700-T2 (DE)
Inventor: NUMMY LAURENCE JOHN
IPC: C07C271/00
Filed: 1987-10-27
Granted: 1994-12-15
Abstract: A process is disclosed whereby mono- and diurethane cyclohexyl derivatives are obtained corresponding to the Lewis acid-catalyzed addition reaction of dipentene and methyl carbamate at a temperature of from about 40 DEG  to about 150 DEG C. The mono- and diurethane cyclohexyl derivatives are pyrolytically converted to other corresponding mono- and diisocyanate cyclohexyl derivatives. Novel vinyl unsaturated monoisocyanate cyclohexyl derivatives useful as reactants for polyfunctional compounds to produce cured compositions are disclosed.
Patent DE-3850915-T2 (DE)
Inventor: ANDERSON DAVID M
IPC: H01M50/426
Filed: 1988-05-20
Granted: 1995-03-09
Abstract: A new type of polymeric microporous membrane has been synthesized which is distinguished by a highly-branched porespace morphology that is continuous and triply-periodic, and thus very precisely controlled and easily characterized. The membrane consists of a polymeric matrix containing pores of diameter on the order of 10 nm connected into a continuous pore network exhibiting long-range three-dimensional order. This long-range order is evidenced in small-angle X-ray scattering (SAXS) experiments by Bragg reflections that index to a triply-periodic space group, as well as in electron micrographs that match predictions from a theoretical model of the same space group and lattice parameter. The membrane combines three important features that have not been present simultaneously in any prior art membrane having pore diameters between 2 nm and 1 micron. First, the pores are identical in size and shape to a very high degree, and their size can be controlled in the synthesis. Second, the porespace is characterized by intricate branching and reconnections, with at least three pore throats meeting at a given pore body, this number (the coordination number) being the same for each pore body, and the porespace is isotropic in the cases where the space group is cubic. These two features allow accurately controlled sieving on the basis of particle size and shape, and provide highly accessible and precisely shaped pore bodies and surfaces for other applications such as catalysis, ion exchange, and the preparation of metal microstructures. And third, the membrane has a high porosity -- approximately 90% -- so that high rates of throughput can be reached. In addition, the membrane can be produced from certain microstructured fluid phases that are thermodynamic equilibrium states, so that it can be produced inexpensively and reliably.
Patent DE-3873528-T2 (DE)
Inventor: LOPEZ-BERESTEIN GABRIEL
IPC: C07H17/08
Filed: 1988-03-02
Granted: 1993-01-21
Abstract: The present invention involves a liposomal agent for treating disseminated fungal infection in an animal. This liposomal agent comprises the polyene antifungal compound nystatin. The nystatin is encapsulated within a liposome. The liposome in which the nystatin is incorporated is preferably a stable multilamellar vesicle. The liposome broadly comprises one or more lipids one or more of phosphomonoglyceride, phosphatidic acid and sphingolipid. The lipids are preferably one or more of phosphatidylcholine, phosphatidylserine, phosphatidylglycerol, sphingomyelin or phosphatidic acid. The lipids are most preferably one or more of dimyristoylphosphatidylcholine, dimyristoylphosphatidylglycerol, phosphatidylcholine and phosphatidylglycerol. The liposome of the present invention may comprise a sterol most preferably cholesterol. An important aspect of the present invention involves a method for treating disseminated fungal infection in an animal. This method comprises administering to an animal subject to disseminated fungal infection a fungicidally effective amount of nystatin encapsulated within a liposome. The liposome is composed as described above. The administering is preferably parenteral in most instances but may be oral or topical if specific colonies of fungus are thereby more directly reached. This treatment method is most useful when the animal is a human suffering from disseminated fungal infection. The method of treatment involves a fungicidally effective amount of liposome-incorporated nystatin of between about 1 mg nystatin/kg body weight and about 6 mg nystatin/kg body weight. In a most preferred embodiment the treatment method comprises liposomes consisting essentially of dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol in a ratio of about 7:3.
Patent DE-3875590-T2 (DE)
Inventor: ISHIKAWA TOMIHISA
IPC: B01D53/86
Filed: 1988-11-10
Granted: 1993-03-25
Abstract: A denitration reactor comprises an entrance duct portion (1) into which exhaust gas (G) from a boiler flows, an intermidiate duct portion (10) incorporating therein a catalyst layer (4) for denitration, and an exit duct portion (5) connected to the intermediate duct portion (10). The intermediate duct portion (10) is so disposed that an axis thereof is perpendicular to an axis of the entrance duct portion (1). The reactor further comprises a bent portion (2) for connecting the entrance duct portion (1) to the intermediate duct portion (10), and a flow controller (3). The wall (2a) of the bent portion (2) is inclined with an inclination angle theta  and extends from a section on which one wall (10a) of the intermediate duct portion (10) crosses a surface of a floor (1a) of the entrance duct portion (1) to a section on which a plane including opposite wall (10b) of the intermediate duct portion (10) crosses a roof (1b) of the entrance duct portion (1). The flow controller (3) is so disposed in the intermediate duct portion (10) that an exhaust gas introduction surface of the flow controller (3) coexists with the floor (1a) of the entrance duct portion (1) on the same plane.
Patent DE-3879875-T2 (DE)
Inventor: BEST ERIC THOMAS
IPC: A23L19/00
Filed: 1988-11-09
Granted: 1993-07-08
Abstract: In order to obtain light, dry, crisp, uniformly-flavoured snacks, an aerated plastic composition of edible components is shaped and heated under vacuum, the composition comprising water; a particulate cookable material; a film-forming material in an amount sufficient to coat at least a substantial proportion of the cookable material; and a viscosity modulator (a material having a viscosity which decreases on heating) in an amount sufficient to compensate at least partially for an increase in the viscosity of the composition (owing to water loss) on heating.
Patent DE-3885252-T2 (DE)
Inventor: ROSATI ROBERT LOUIS
IPC: C07D209/42
Filed: 1988-12-14
Granted: 1994-02-17
Abstract: Simple amides and derivatives thereof useful for inhibiting the angiotensinogen-cleaving action of the enzyme renin of the formula: <CHEM> wherein R1 is (C6-C8)cycloalkyl or i-propyl; R2 is (C3-C5)alkyl, phenyl, methylvinyl, dimethylvinyl, halovinyl, hydroxy(C1-C3)alkyl or amino(C1-C4)alkyl; R3 is (C1-C6)alkyl or morpholinoethyl; and Het is defined to include certain mono and bicyclic nitrogen-containing heterocyclic rings or heterocyclylalkyl groups.
Patent DE-3889264-T2 (DE)
Inventor: AWAYA AKIRA
IPC: C07D401/04
Filed: 1988-08-25
Granted: 1994-08-11
Abstract: Compounds of formula <CHEM> where X is -NR<1>R<2> or SR<4>; Y is amino optionally substituted by alkyl; Z is methyl substituted by alkoxy carbonyl or alkoxycarbonyl or Y and Z together may form a divalent group -X-Y- of formula <CHEM> . The compounds are useful in the treatment if neurological diseases of the pheripheral and central nervous systems of animals.
Patent DE-3889667-T2 (DE)
Inventor: WILSON HAROLD
IPC: C25D3/56
Filed: 1988-10-14
Granted: 1994-10-13
Abstract: Baths are disclosed for electrodepositing bismuth-tin alloys of all ratios as shown by the Figure. The baths are of the acidic alkylsulfonate-type. Soluble bismuth anodes are used to replenish bismuth in the bath solution. The baths find particular use in electrodepositing eutectic compositions such as 58 % Bi-42 % Sn.
Patent TR-199902681-T2 (TR)
Inventor: AMMERMANN EBERHARD
IPC: C12N15/82
Filed: 1998-04-16
Abstract: Bitkilerde bir küf öldürücü madde-tutucu antikoru göstermek kaydiyla küf öldürücü madde-toleransli bitkiler üretme süreci.
Patent DE-60000152-T2 (DE)
Inventor: HASHIMOTO MASAYA
IPC: G01F19/00
Filed: 2000-02-09
Granted: 2003-03-06
Abstract: A dispensing container including an oblong container body (12) with a removable seal (14) engaged thereto and having a discharge spout (46) selectively closed by a cap (72) pivotally mounted to the seal by a connecting strap (74) with an offset central portion. The connecting strap has an outer end releasably pivotally joined to the seal with the cap, upon complete removal from the seal, defining a measuring cup horizontally positionable on a flat surface by an intermediate offset formed within the connecting strap. <IMAGE>
Patent DE-60005412-T2 (DE)
Inventor: SATO SHIGERU
IPC: B28D5/02
Filed: 2000-01-20
Granted: 2004-05-06
Abstract: An ultrasonic vibration cutting method comprising mounting and fixing a part to be cut on a mounting table, moving down an ultrasonic vibration rotation unit, stopping the downward movement of the ultrasonic vibration rotation unit when the cutting blade of the ultrasonic vibration rotation unit reaches a position for cutting the part, moving the ultrasonic vibration rotation unit linearly for cutting, and turning and vibrating the cutting blade with ultrasonic waves to cut the part. <IMAGE>
Patent DE-60005493-T2 (DE)
Inventor: OXFORD ALEXANDER WILLIAM
IPC: A61P11/06
Filed: 2000-03-29
Granted: 2004-07-01
Abstract: The present invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their application as inhibitors of phosphodiesterase (PDE) isoenzymes. More particularly the invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their use in medicine for example as bronchodilators with anti-inflammatory properties.
Patent DE-60005526-T2 (DE)
Inventor: BAXTER SMITH
IPC: A61P1/00
Filed: 2000-07-28
Granted: 2004-07-01
Abstract: The present invention relates to the use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrinxidine, and salts or N-oxides thereof, in the treatment of disorders of the gastro-intestinal tract, in particular for the treatment of irritable bowel syndrome (IBS).
Patent DE-60006255-T2 (DE)
Inventor: JANSSEN HUBERTUS
IPC: H04R25/00
Filed: 2000-08-14
Granted: 2004-08-12
Abstract: A hearing aid comprising memory means for storing preset signal processing parameters, and adjusting means for the stepwise adjustment of one or more of the stored signal processing parameters from a starting point of a predetermined range to an end point of said range. Examples of signal processing parameters to be adjusted are high tone amplification, maximum output level and noise suppression threshold value. Examples of providing the trigger signals include: a time clock, repeated turning on of the hearing aid, repeated placing of a battery and repeated operation of a knob. The hearing aid may be arranged for mutual communication with an external unit. The external unit may include selection means for the setting in the adjusting means of the one or more parameters to be adjusted, range setting means for the setting in the adjusting means of the range of the one or more parameters to be adjusted, step magnitude setting means for the setting in the adjusting means of a step magnitude to be used in said setpwise adjustment, and interval setting means for the setting of the repeat interval of the successive trigger signals in the time clock. The hearing aid carries out the adjustment autonomously in inaudible steps.
Patent DE-60011134-T2 (DE)
Inventor: SUZUKI KOUJI
IPC: H02M5/458
Filed: 2000-12-18
Granted: 2005-06-23
Abstract: An engine-driven portable generator using an inverter may still generate a voltage at its output terminals even though the engine is stopped. In view of this problem, the invention is to provide a portable generator, which is intended to prevent any residual voltage from generating between the output terminals. That is, a portable generator rectifying once an AC voltage into a DC voltage, converting the DC voltage into a single-phase AC voltage, and outputting the single-phase AC voltage, which has an output-stop-control unit (443) that, when an operating switch (305) is turned off, stops the operation of the inverter circuit at the timing when the voltage between the output terminals drops to 0, is provided. <IMAGE>
Patent DE-60014191-T2 (DE)
Inventor: HOORNAERT SIGVARD
IPC: D06F33/48
Filed: 2000-11-24
Granted: 2005-09-29
Abstract: A machine having a rotating container as well as at least one balancing chamber which is fillable with a liquid for correcting out-of-balance rotational operation of the container and a method of operating the machine is described. A degree of out of balance operation of the container is detected at a position in a sub-system of the machine at which a ratio of a maximum rotational frequency of the drum to the resonant frequency of the sub-system is less than 90 %, more preferably less than 85 % and most preferably less than 80 % and injecting the liquid into the at least one balancing chamber to correct for out-of-balance operation of the rotating container based on the detecting step.
Patent DE-60017370-T2 (DE)
Inventor: HARRIS GRAHAM
IPC: B65H45/30
Filed: 2000-02-17
Granted: 2005-12-22
Abstract: The invention is a creasing device for creasing paper or card before it is folded. The device consists of a drum-shaped male component (2) featuring grooves (8, 10, 12) of various widths and depths to hold rubber O-rings (24, 26, 28). A female component (4) is almost identical to the male component (2) but has receiving grooves (14, 16, 18) that are slightly wider and deeper. When fixed to top and bottom shafts with one O-ring (24, 26, 28) in a groove (8, 10, 12) on the male component (2) aligned with a receiving groove (14, 16, 18) of the female component (4), a sheet of paper fed between the drums will be creased by the pressure of the O-ring (24, 26, 28) forcing the paper into the receiving groove (14, 16, 18). The invention allows the device to be quickly and easily set up to form creases of various widths and depths, while the resilient O-rings minimize damage to the paper.
Patent DE-60019446-T2 (DE)
Inventor: JANSEN HUBERT
IPC: A61J1/00
Filed: 2000-10-06
Granted: 2006-02-23
Abstract: An improved transferset assembly for transferring fluids between a first container, such as a medicament vial and a second container, such as a syringe, which includes an integral polymeric transfer assembly having a tubular collar portion, a radial portion overlying the rim of the first container, an outer tubular portion and an inner tubular portion which is integrally joined to the outer tubular portion by a radial intermediate web portion, a piercing member telescopically received in the inner tubular portion having a piercing end to pierce the closure sealing the open end of the first container and a removable closure which seals the open ends of the outer and inner tubular portions of the transfer assembly. The tubular collar portion, which may be separate from the inner and outer tubular portions, is formed of composite polymer including a relatively soft polymer and a relatively rigid polymer, such that the free end of the collar portion may be deformed radially inwardly or crimped into the neck of the first container, yet sufficiently rigid to retain its shape following deformation and resistant to creep to maintain a seal between the transfer assembly and the first container. The proximate end of the inner tubular portion includes a sharp edge which seals against the closure of the first container. The preferred embodiment of the closure is frangibly connected to the free end of the outer tubular portion of the transfer assembly and provides a biological seal.
Patent DE-60024191-T2 (DE)
Inventor: OGUCHI ASAHIRO
IPC: B41J13/00
Filed: 2000-09-28
Granted: 2006-07-20
Abstract: Printer control prevents a user from pulling printed roll paper before it is cut off the roll while still providing the printed paper quickly to the user. When the printing of the paper ends and before cutting the paper by a paper cutting mechanism (13) is completed, paper is ejected from an ejection opening (11) by driving ejection rollers (15, 16). When a paper sensor (17) detects the trailing end of paper, paper is held by ejection rollers (16) to hold the trailing end of the paper ejected from ejection opening (11) and wait for the user to remove the paper from the opening. <IMAGE>
Patent DE-60025191-T2 (DE)
Inventor: DANIELSSON MATS
IPC: G21K1/02
Filed: 2000-04-03
Granted: 2006-08-31
Abstract: The invention relates to a scanned-slot x-ray imaging system, having a first collimator and a second collimator arranged in a first distance (a) and a second distance (b), respectively, from a radiation source and each provided with a slot and a detector located under the second collimator slot, said slot of said second collimator being wider than the said slot of said first collimator and said detector under the second slot is wider than the first collimator slot and the second collimator slot. The slot of said second collimator has a width (y') not less than a safety margin and the product of the width (x) of the slot of said first collimator and said second distance (b) divided with the said first distance (a) for allowing a misalignment with respect to a central symmetry line of said slots.
Patent DE-60025264-T2 (DE)
Inventor: BRAITHWAITE PHILIP
IPC: A61J3/00
Filed: 2000-10-20
Granted: 2006-08-24
Abstract: There is described a medicament dosage unit (1) comprising a sleeve (12) and a medicament holding chamber (2) adapted to form a slidable fit within the sleeve (12), the sleeve (12) and the chamber (2) being dimensioned such that the sleeve (12) extends beyond the length of the chamber (2), and the unit being provided with an openable closure member (6). There is also described a cartridge comprising (112) a plurality of such dosage units and a delivery device adpated for the use of individual dosage units of a cartridge.
Patent DE-60026357-T2 (DE)
Inventor: ZENTNER M
IPC: C08L101/00
Filed: 2000-11-10
Granted: 2006-10-19
Abstract: A polymer blend is prepared by dissolving chitosan and a second polymer in an acidic aqueous solution to form an aqueous polymer blend, dehydrating said aqueous polymer blend, and recovering said polymer blend. The second polymer may be selected from the group consisting of polyether glycols including polyethylene glycols; cellulose esters including cellulose acetate; poloxamers; polysaccharides including dextran and guar; polyvinylpyrrolidones; polyvinyl alcohols; and mixtures or copolymers thereof. These polymer blends swell in an acidic environment and deswell in a more neutral or basic environment. This technology is valuable for the dispensing of biologically active material or drugs into a surrounding environment, especially the environment as is found in the gastrointestinal tract. Since the various polymer blends of the present invention are not covalently or ionically crosslinked, but are physically combined, each polymer in the physical blend maintains its original chemical structure, and therefore, is safe for oral administration.
Patent DE-60028559-T2 (DE)
Inventor: SADOUL REMY
IPC: A61K38/21
Filed: 2000-03-20
Granted: 2006-10-05
Abstract: The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantages the use of GH together with IFN- beta  to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.
Patent DE-60032019-T2 (DE)
Inventor: OSBORN E
IPC: A61G7/00
Filed: 2000-12-29
Granted: 2007-03-29
Abstract: A patient support (10) comprising a frame including a base frame (32), an intermediate frame (52), and a plurality of lift arms (58,60) configured to move the intermediate frame relative to the base frame, a deck (14) supported by the intermediate frame, a headboard coupled to the base frame, and a footboard supported by the intermediate frame.